Diligence memo · auto-generated · as of July 2, 2026

Optical X, Inc.

Optical X, Inc. looks under-valued against its niche peers and is quiet on financing cadence.

SourceModeled below same-niche peers while still financing on rhythm — a potential mispricing worth a closer look.

Businessfiled

Optical X, Inc. operates in Other Health Care, based in MADISON.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

Optical X, Inc. has raised $1.9M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).

Largest single filing: $1.9M on 2024-10-15.

Most recent recorded round closed around 2024-10-15.

Valuation (modeled)modeled

Provath models Optical X, Inc. at approximately $7.6M (range $1.6M–$19M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.64× the median modeled value of Seed Other Health Care companies in 2022–2024 (244 peers) — value vs value, same stage and era. Issuer reports $1M–$5M revenue while modeled below niche peers.

Financing rhythm & timingmixed

Last raise 21 mo ago; this sector typically re-raises about every 14 months.

Slightly overdue versus sector cadence.

Comparablesmixed

Capital scale ranks ahead of 46% of Other Health Care peers (5377 compared).

Modeled value ranks above 29% of those peers.

Closest niche peers: Elmntri LLC, Atreo, Inc., descendantsDNA, Inc., Westover Project Investor LLC, Dentulu Inc.

Peoplefiled

2 named people on file across officers, directors and signatories.

Risks & flagsmixed

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.